Abstract
Background The COVID-19 pandemic has overwhelmed hospitals in several areas in high-income countries. An effective response to this pandemic requires healthcare workers (HCWs) to be present at work, particularly in low- and middle-income countries (LMICs) where they are already in critically low supply. To inform whether and to what degree policymakers in Bangladesh, and LMICs more broadly, should expect a drop in HCW attendance as COVID-19 continues to spread, this study aims to determine how HCW attendance has changed during the early stages of the COVID-19 pandemic in Bangladesh.
Methods This study analyzed daily fingerprint-verified attendance data from all 527 public-sector secondary and tertiary care facilities in Bangladesh to describe HCW attendance from January 26, 2019 to March 22, 2020, by cadre, hospital type, and geographic division. We then regressed HCW attendance onto fixed effects for day-of-week, month, and hospital, as well as indicators for each of three pandemic periods: a China-focused period (January 11, 2020 [first confirmed COVID-19 death in China] until January 29, 2020), international-spread period (January 30, 2020 [World Health Organization’s declaration of a global emergency] until March 6, 2020), and local-spread period (March 7, 2020 [first confirmed COVID-19 case in Bangladesh] until the end of the study period).
Findings On average between January 26, 2019 and March 22, 2020, 34·1% of doctors, 64·6% of nurses, and 70·6% of other healthcare staff were present for their scheduled shift. HCWs’ attendance rate increased with time in 2019 among all cadres. Nurses’ attendance level dropped by 2·5% points (95% CI; –3·2% to –1·8%) and 3·5% points (95% CI; –4·5% to –2·5%) during the international-spread and the local-spread periods of the COVID-19 pandemic, relative to the China-focused period. Similarly, the attendance level of other healthcare staff declined by 0·3% points (95% CI; –0·8% to 0·2%) and 2·3% points (95% CI; –3·0% to –1·6%) during the international-spread and local-spread periods, respectively. Among doctors, however, the international-spread and local-spread periods were associated with a statistically significant increase in attendance by 3·7% points (95% CI; 2·5% to 4·8%) and 4·9% points (95% CI; 3·5% to 6·4%), respectively. The reduction in attendance levels across all HCWs during the local-spread period was much greater at large hospitals, where the majority of COVID-19 testing and treatment took place, than that at small hospitals.
Conclusions After a year of significant improvements, HCWs’ attendance levels among nurses and other healthcare staff (who form the majority of Bangladesh’s healthcare workforce) have declined during the early stages of the COVID-19 pandemic. This finding may portend an even greater decrease in attendance if COVID-19 continues to spread in Bangladesh. Policymakers in Bangladesh and similar LMICs should undertake major efforts to achieve high attendance levels among HCWs, particularly nurses, such as by providing sufficient personal protective equipment as well as monetary and non-monetary incentives.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Pascal Geldsetzer was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR003143. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is exempted from ethics approval because the dataset generated and/or analyzed during the current study is publicly available on the Bangladesh Ministry of Health and Family Welfare website [15]: http://103.247.238.92/dghseams/attend/.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset generated and/or analyzed during the current study is publicly available on the Bangladesh Ministry of Health and Family Welfare website [15]: http://103.247.238.92/dghseams/attend/.
